Login

Global Pharmaceutical Manufacturer Begins Work On First Phase of Major New Facility in Delaware

China-Based WuXi STA Building 190-Acre Pharmaceutical Manufacturing Campus in the Middletown Business Center
The U.S. affiliate of China-based WuXi AppTech, one of the world's largest pharmaceutical services firms, has begun construction on a sprawling pharmaceutical manufacturing campus in Middletown, Delaware. (Delaware Prosperity Partnership)
The U.S. affiliate of China-based WuXi AppTech, one of the world's largest pharmaceutical services firms, has begun construction on a sprawling pharmaceutical manufacturing campus in Middletown, Delaware. (Delaware Prosperity Partnership)
By Lauren Diggs
CoStar Research
August 19, 2022 | 7:15 P.M.

WuXi STA, the U.S. affiliate of a global pharmaceutical services firm based in China, broke ground on a new 190-acre pharmaceutical manufacturing campus in located in the Middletown Business Center at 1091 Industrial Drive after selecting the Delaware site in 2021. This will be WuXi STA's second U.S. facility. It also has manufacturing sites in Switzerland and China.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE


News | Global Pharmaceutical Manufacturer Begins Work On First Phase of Major New Facility in Delaware